Genome British Columbia (Genome BC), a not-for-profit genomics research company, has secured $49 million in funding for five projects that will be conducted in British Columbia and will utilize genomics to advance personalized healthcare.According…
Continue Reading
Chatbots powered by artificial intelligence are emerging as meaningful tools in remote patient monitoring and chronic disease management, with the potential to improve diagnostic accuracy, support clinicians, and boost patient adherence.These were among the…
Continue Reading
What You Should Know:
– A new report from KLAS Research examines the use of artificial intelligence (AI) and machine learning (ML) within healthcare data science solutions.
– The KLAS report, which builds upon a previous…
Continue Reading
The Promise of EHDS for European Healthcare
The European Health Data Space (EHDS) represents a groundbreaking initiative launched by the European Commission in 2022 to revolutionize healthcare across the continent. At its core, EHDS aims…
News
[embedded content]
Amazon releases Nova Act, an AI model that can perform actions within a web browser.
An Israel-based medical advocacy group urges the health ministry to develop AI usage guidelines and enforcement, citing…
What You Should Know:
– University Hospitals Cleveland Medical Center (UH) has announced a groundbreaking collaboration with global healthcare Artificial Intelligence (AI) innovator Qure.ai to deploy chest X-ray AI supporting earlier identification of lung cancers.
– The…
Continue Reading
Unlearn, an AI-enabled company creating digital twins of clinical trial participants, announced a partnership to advance ALS research with biotechnology company Trace Neuroscience, which creates genomic therapies for neurodegenerative diseases.Unlearn, founded in 2017, uses…
Continue Reading
The Oxford Dictionary says disease is a disorder of structure or function, especially one that has a known cause and a distinctive group of symptoms, signs, or anatomical changes. It’s time to rethink that…
Continue Reading
A federal judge in Texas ruled that the FDA overstepped its authority when it issued its Final Rule: Medical Devices; Laboratory Developed Tests in May of last year, which said laboratory-developed tests (LDTs) should…
Continue Reading
In part one, we discussed the shortcomings of evidence-based medicine and the disconnect between RCTs and bedside clinical care. Part 2 explores possible solutions, including machine learning based algorithms.
By Paul Cerrato, MA, senior research…
Continue Reading
